C12Y 301/27
Endoribonucleases producing 3'-phosphomonoesters
Official title: Endoribonucleases producing 3'-phosphomonoesters (3.1.27)
C12Y301/27 (Endoribonucleases producing 3'-phosphomonoesters) appears on 126 US grants and 210 published applications in this corpus.
Search patents in C12Y- Granted patents
- 126
- Published applications
- 210
- Assignees
- 95
- Inventors
- 259
- Latest grant
- 3 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 4 | 1 |
| 2003 | 1 | 0 |
| 2004 | 2 | 1 |
| 2005 | 0 | 4 |
| 2006 | 1 | 1 |
| 2007 | 0 | 2 |
| 2008 | 1 | 2 |
| 2009 | 0 | 3 |
| 2010 | 1 | 3 |
| 2011 | 3 | 5 |
| 2012 | 4 | 9 |
| 2013 | 4 | 14 |
| 2014 | 12 | 17 |
| 2015 | 7 | 25 |
| 2016 | 8 | 20 |
| 2017 | 13 | 25 |
| 2018 | 9 | 8 |
| 2019 | 9 | 14 |
| 2020 | 6 | 7 |
| 2021 | 6 | 8 |
| 2022 | 7 | 12 |
| 2023 | 6 | 10 |
| 2024 | 5 | 8 |
| 2025 | 8 | 6 |
| 2026 | 1 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 301/27005Pancreatic ribonuclease68
- C12Y 301/27003Ribonuclease t18
- C12Y 301/27004Ribonuclease u25
- C12Y 301/27001Ribonuclease t24
- C12Y 301/27008Ribonuclease v3
- C12Y 301/2701Rrna endonuclease3
- C12Y 301/27002Bacillus subtilis ribonuclease2
- C12Y 301/27009Trna-intron endonuclease2
All 10 subgroupsShow fewer
Recent patents
- Biomarkers for the early detection of breast cancer3 Feb 2026US 12,540,940 B2Arizona Board of Regents
- Polynucleotides encoding APOA-1 fusion polypeptides30 Dec 2025US 12,509,501 B2Theripion, Inc.
- Methods for mapping personalized translatome11 Nov 2025US 12,467,048 B2Northwestern University
- Therapeutic nuclease compositions and methods7 Oct 2025US 12,435,322 B2University of Washington
- Composition and method for treating or prophylaxis of coronavirus and cancers1 Jul 2025US 12,343,322 B2Betahealth LLC
- Assay of rna poly(a) tail length27 Aug 2026US 2026/0250762 A1Cellscript, LLC
- Biomarkers for the early detection of breast cancer14 May 2026US 2026/0133199 A1President and Fellows of Harvard College
- Methods for treating acute coronary syndrome using apoa-1 fusion proteins5 Mar 2026US 2026/0062460 A1Theripion, Inc.
- Therapeutic Nuclease Compositions and Methods12 Feb 2026US 2026/0043012 A1University of Washington
- Therapeutic nuclease compositions and methods5 Feb 2026US 2026/0035680 A1University of Washington
Most cited
By later US patents
- Modulated release from biocompatible polymers263US 5,656,297 AAlkermes Controlled Therapeutics, Inc. · 1997
- Formulation of a reconstituted protein, and method and kit for the production thereof234US 5,580,856 A1996
- Modulated release from biocompatible polymers226US 5,912,015 AAlkermes Controlled Therapeutics, Inc. · 1999
- Engineered nucleic acids and methods of use thereof184US 9,464,124 B2Moderna Therapeutics, Inc. · 2016
- Modification of protein by use of a controllable interveining protein sequence95US 5,496,714 ANew England Biolabs, Inc. · 1996